The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations

September 2025 in “ Healthcare ”

Jonathan Shaw, Charles Lai, Peter Bota, Andrew Le, Anton Andricioaei, Theodore Tran, Tina Allee

TLDR SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Selective Serotonin Reuptake Inhibitors (SSRIs) are often used off-label to manage inappropriate sexual behavior in geriatric patients with dementia due to their safer profile compared to antipsychotics. However, the risk of Post-SSRI Sexual Dysfunction (PSSD) remains unclear and can be a severe, long-lasting condition. The current literature is mostly based on case reports or theoretical papers, highlighting the need for high-quality clinical trials to better understand the risks and treatment options associated with SSRIs in this context.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

Insights Into the Peripheral Nature of Persistent Sexual Dysfunction Associated With Post-Finasteride, Post-SSRI, and Post-Accutane Syndromes: Lessons Learned From a Case Study

research Insights Into the Peripheral Nature of Persistent Sexual Dysfunction Associated With Post-Finasteride, Post-SSRI, and Post-Accutane Syndromes: Lessons Learned From a Case Study

February 2025 in “International Urology and Nephrology”

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

research Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction: Two Clinically Similar Conditions

November 2023 in “Frontiers in Neuroendocrinology”

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

research Estimating the Risk of Irreversible Post-SSRI Sexual Dysfunction Due to Serotonergic Antidepressants

11 citations , April 2023 in “Annals of General Psychiatry”

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

research Diagnostic Criteria for Enduring Sexual Dysfunction After Treatment With Antidepressants, Finasteride, and Isotretinoin

8 citations , October 2021 in “The international journal of risk and safety in medicine”

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Post-Finasteride Syndrome: An Emerging Clinical Problem

The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations

Research cited in this study

research Insights Into the Peripheral Nature of Persistent Sexual Dysfunction Associated With Post-Finasteride, Post-SSRI, and Post-Accutane Syndromes: Lessons Learned From a Case Study

research Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction: Two Clinically Similar Conditions

research Estimating the Risk of Irreversible Post-SSRI Sexual Dysfunction Due to Serotonergic Antidepressants

research Diagnostic Criteria for Enduring Sexual Dysfunction After Treatment With Antidepressants, Finasteride, and Isotretinoin

research Post-Finasteride Syndrome: An Emerging Clinical Problem

research Neuroactive Steroid Levels and Psychiatric and Andrological Features in Post-Finasteride Patients

research Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-Analysis